Back to Search
Start Over
Controlled Clinical Trial of L-Dopa and Nafoxidine in Advanced breast Cancer: An E.O.R.T.C. Study
- Source :
- British medical journal, 2 (5973
- Publication Year :
- 1975
-
Abstract
- L-Dopa lowers plasma prolactin levels, and there have been reports that patients with advanced breast cancer have been successfully treated with L-dopa. To test the potential value of L-dopa in this disease a randomized clinical trial of L-dopa and nafoxidine (as the reference compound) was conducted in postmenopausal women with advanced breast cancer. Objective remissions were obtained in seven out of 36 patients (19%) treated with nafoxidine but in none out of 40 patients treated with L-dopa. L-Dopa in the dose schedule used seems to be ineffective in advanced breast cancer. © 1975, British Medical Journal Publishing Group. All rights reserved.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- British medical journal, 2 (5973
- Notes :
- 1 full-text file(s): application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.ocn961114020
- Document Type :
- Electronic Resource